Tuoxin Pharmaceutical: Shareholder Ivy Trade Co., Ltd. has reduced its shareholding in the company by 0.23%.

New Drug Industry Announcement: The company's stock deviated by 45.65% on May 15th and 16th, 2025, for two consecutive trading days, which is considered abnormal volatility. Upon verification, there is no information disclosed by the company that requires correction or supplementation. Recently, no significant undisclosed information that may have a major impact on the company's stock trading price has been found. The controlling shareholder and actual controller of the company have no significant undisclosed matters that need to be disclosed. Shareholder Ivos Trading Co., Ltd. reduced its stake through centralized bidding and block trading during the abnormal stock volatility period, accounting for 0.23% of the total share capital. The company had a net loss of -1988.49 million yuan in 2024, a decrease of 108.18% compared to 2023; and a net loss of -356.47 million yuan in the first quarter of 2025, a decrease of 272.34% compared to the same period last year.